Multicancer Early Detection: A Fellow’s Perspective With Waqas Haque, MD, MPH
Update: 2025-07-25
Description
Advancements in medical technology are transforming cancer screening, with multicancer early detection (MCED) testing leading the way. Dr. Waqas Haque, a Hematology/Oncology Fellow at the University of Chicago, recently shared his perspectives on i3 Health’s CME activity, Optimizing Cancer Screening with MCED Technologies: From Science to Practical Application. With MCED testing moving from research to real-world practice, Dr. Haque discussed the science, challenges, and future of these innovative tests, as well as the importance of staying up to date on emerging advances with continuing education.
Click the links below for the full CME activity!
Module 1: bit.ly/3X8apxa
Module 2 : bit.ly/41rS14I
Module 3: bit.ly/4b9JU00
And view the slide decks here:
Module 1: bit.ly/4l0NTzc
Module 2: bit.ly/4fdXwti
Module 3: bit.ly/40AkmoP
Click the links below for the full CME activity!
Module 1: bit.ly/3X8apxa
Module 2 : bit.ly/41rS14I
Module 3: bit.ly/4b9JU00
And view the slide decks here:
Module 1: bit.ly/4l0NTzc
Module 2: bit.ly/4fdXwti
Module 3: bit.ly/40AkmoP
Comments
In Channel